Key result
Nebivolol improves arterial stiffness and endothelial function to a greater extent than older beta-blockers, likely due to its vasodilating properties and ability to enhance nitric oxide release.
Why the study?
Does nebivolol improve arterial stiffness compared to older beta-blockers in patients with hypertension?
Population
Patients with hypertension and cardiovascular diseases
Comparison
Nebivolol vs Older beta-blockers (e.g., atenolol)
Design
Review
Authors
Loading...
May support nebivolol preference for vascular benefits in hypertension; leaves open need for outcome trials versus older agents.
Does nebivolol improve arterial stiffness compared to older beta-blockers in patients with hypertension?
Nebivolol's ability to enhance nitric oxide release and improve arterial stiffness may provide significant clinical benefits in treating hypertension compared to older beta-blockers.
Enrico Agabiti‐Rosei (2009) conducted a review in Hypertension and cardiovascular diseases. Nebivolol vs. Older beta-blockers (e.g., atenolol) was evaluated on Arterial stiffness and endothelial function. Nebivolol improves arterial stiffness and endothelial function to a greater extent than older beta-blockers, likely due to its vasodilating properties and ability to enhance nitric oxide release.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: